Stability in eosinophil categorisation during subsequent severe exacerbations of COPD

BACKGROUND: The blood eosinophil count has been shown to be a promising biomarker for establishing personalised treatment strategies to reduce corticosteroid use, either inhaled or systemic, in chronic obstructive pulmonary disease (COPD). Eosinophil levels seem relatively stable over time in stable...

Descripción completa

Detalles Bibliográficos
Autores principales: Citgez, Emanuel, van der Palen, Job, van der Valk, Paul, Kerstjens, Huib A M, Brusse-Keizer, Marjolein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Chronic Obstructive Pulmonary Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354268/
https://www.ncbi.nlm.nih.gov/pubmed/34376399
http://dx.doi.org/10.1136/bmjresp-2021-000960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354268/
https://www.ncbi.nlm.nih.gov/pubmed/34376399
http://dx.doi.org/10.1136/bmjresp-2021-000960

Ejemplares similares